Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,617
NCT00454688
Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2006
Completion: Dec 31, 2007
NCT00443040
Asimadoline for the Treatment of Post-Operative Ileus
Start: Jan 31, 2007
Completion: Feb 29, 2008
NCT01100684
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Phase: Phase 3
Start: May 31, 2010
Completion: Jun 30, 2013
NCT01380561
A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers
Phase: Phase 1
Start: Jun 30, 2011
Completion: Jul 31, 2011
NCT02475447
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
Start: Jul 31, 2015
Completion: Jun 30, 2017
NCT07042516
Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).
Start: Aug 13, 2025
Completion: Feb 20, 2027